{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T21:05:28Z","timestamp":1765487128799},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,13]]},"DOI":"10.7759\/cureus.69356","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T18:35:54Z","timestamp":1726252554000},"source":"Crossref","is-referenced-by-count":1,"title":["Synucleins As Biomarkers of Severity in Autism Spectrum Disorder"],"prefix":"10.7759","author":[{"given":"Lal","family":"D. V. Nair","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senthil Kumar","family":"Sivanesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devika S","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43226","article-title":"Early diagnosis of autism spectrum disorder: a review and analysis of the risks and benefits","volume":"15","author":"Okoye C","year":"2023","unstructured":"Okoye C, Obialo-Ibeawuchi CM, Obajeun OA, et al.. Early diagnosis of autism spectrum disorder: a review and analysis of the risks and benefits. Cureus. 2023, 15:e43226. 10.7759\/cureus.43226","journal-title":"Cureus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000203","article-title":"Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study","volume":"4","author":"Raghavan K","year":"2022","unstructured":"Raghavan K, Dedeepiya VD, Ikewaki N, Sonoda T, Iwasaki M, Preethy S, Abraham SJ. Improvement of behavioural pattern and alpha-synuclein levels in autism spectrum disorder after consumption of a beta-glucan food supplement in a randomised, parallel-group pilot clinical study. BMJ Neurol Open. 2022, 4:e000203. 10.1136\/bmjno-2021-000203","journal-title":"BMJ Neurol Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000513935","article-title":"Plasma levels of alpha and gamma synucleins in autism spectrum disorder: an indicator of severity","volume":"30","author":"Al-Mazidi S","year":"2021","unstructured":"Al-Mazidi S, Al-Ayadhi LY. Plasma levels of alpha and gamma synucleins in autism spectrum disorder: an indicator of severity. Med Princ Pract. 2021, 30:160-7. 10.1159\/000513935","journal-title":"Med Princ Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2010.12.001","article-title":"The role of \u03b1-synuclein in neurotransmission and synaptic plasticity","volume":"42","author":"Cheng F","year":"2011","unstructured":"Cheng F, Vivacqua G, Yu S. The role of \u03b1-synuclein in neurotransmission and synaptic plasticity. J Chem Neuroanat. 2011, 42:242-8. 10.1016\/j.jchemneu.2010.12.001","journal-title":"J Chem Neuroanat"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28941","article-title":"The alpha and beta synucleins: from pathophysiology to clinical application as biomarkers","volume":"37","author":"Barba L","year":"2022","unstructured":"Barba L, Paolini Paoletti F, Bellomo G, et al.. The alpha and beta synucleins: from pathophysiology to clinical application as biomarkers. Mov Disord. 2022, 37:669-83. 10.1002\/mds.28941","journal-title":"Mov Disord"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01578-7","article-title":"Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: Use of combined ROC curves to increase their diagnostic values","volume":"20","author":"El-Ansary A","year":"2021","unstructured":"El-Ansary A, Alhakbany M, Aldbass A, Qasem H, Al-Mazidi S, Bhat RS, Al-Ayadhi L. Alpha-Synuclein, cyclooxygenase-2 and prostaglandins-EP2 receptors as neuroinflammatory biomarkers of autism spectrum disorders: Use of combined ROC curves to increase their diagnostic values. Lipids Health Dis. 2021, 20:155. 10.1186\/s12944-021-01578-7","journal-title":"Lipids Health Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00028","article-title":"\u03b1-synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling","volume":"13","author":"Huang M","year":"2019","unstructured":"Huang M, Wang B, Li X, Fu C, Wang C, Kang X. \u03b1-synuclein: a multifunctional player in exocytosis, endocytosis, and vesicle recycling. Front Neurosci. 2019, 13:28. 10.3389\/fnins.2019.00028","journal-title":"Front Neurosci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.E14-02-0708","article-title":"Acute increase of \u03b1-synuclein inhibits synaptic vesicle recycling evoked during intense stimulation","volume":"25","author":"Busch DJ","year":"2014","unstructured":"Busch DJ, Oliphint PA, Walsh RB, Banks SM, Woods WS, George JM, Morgan JR. Acute increase of \u03b1-synuclein inhibits synaptic vesicle recycling evoked during intense stimulation. Mol Biol Cell. 2014, 25:3926-41. 10.1091\/mbc.E14-02-0708","journal-title":"Mol Biol Cell"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddl242","article-title":"Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression","volume":"15","author":"Fan Y","year":"2006","unstructured":"Fan Y, Limprasert P, Murray IV, et al.. Beta-synuclein modulates alpha-synuclein neurotoxicity by reducing alpha-synuclein protein expression. Hum Mol Genet. 2006, 15:3002-11. 10.1093\/hmg\/ddl242","journal-title":"Hum Mol Genet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2017.00224","article-title":"Synucleins and gene expression: ramblers in a crowd or cops regulating traffic?","volume":"10","author":"Surguchev AA","year":"2017","unstructured":"Surguchev AA, Surguchov A. Synucleins and gene expression: ramblers in a crowd or cops regulating traffic?. Front Mol Neurosci. 2017, 10:224. 10.3389\/fnmol.2017.00224","journal-title":"Front Mol Neurosci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2001-3-1-reviews3002","article-title":"The synucleins","volume":"3","author":"George JM","year":"2002","unstructured":"George JM. The synucleins. Genome Biol. 2002, 3:3002. 10.1186\/gb-2001-3-1-reviews3002","journal-title":"Genome Biol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s13312-024-3152-x","article-title":"Autism screening in India: many a chasm to bridge","volume":"61","author":"Chattopadhyay N","year":"2024","unstructured":"Chattopadhyay N. Autism screening in India: many a chasm to bridge. Indian Pediatr. 2024, 61:321-2. 10.1007\/s13312-024-3152-x","journal-title":"Indian Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-020-00946-8","article-title":"Patterns of autism symptoms: hidden structure in the ADOS and ADI-R instruments","volume":"10","author":"Lefort-Besnard J","year":"2020","unstructured":"Lefort-Besnard J, Vogeley K, Schilbach L, Varoquaux G, Thirion B, Dumas G, Bzdok D. Patterns of autism symptoms: hidden structure in the ADOS and ADI-R instruments. Transl Psychiatry. 2020, 10:257. 10.1038\/s41398-020-00946-8","journal-title":"Transl Psychiatry"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1007\/BF02408436","article-title":"Toward objective classification of childhood autism: childhood autism rating scale (CARS)","volume":"10","author":"Schopler E","year":"1980","unstructured":"Schopler E, Reichler RJ, DeVellis RF, Daly K. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J Autism Dev Disord. 1980, 10:91-103. 10.1007\/BF02408436","journal-title":"J Autism Dev Disord"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7176.155616","article-title":"Assessment of severity of autism using the Indian scale for assessment of autism","volume":"37","author":"Chakraborty S","year":"2015","unstructured":"Chakraborty S, Thomas P, Bhatia T, Nimgaonkar VL, Deshpande SN. Assessment of severity of autism using the Indian scale for assessment of autism. Indian J Psychol Med. 2015, 37:169-74. 10.4103\/0253-7176.155616","journal-title":"Indian J Psychol Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e05068","article-title":"Mode of delivery, order of birth, parental age gap and autism spectrum disorder among Malaysian children: a case-control study","volume":"6","author":"Andoy Galvan JA","year":"2020","unstructured":"Andoy Galvan JA, Ramalingam PN, Patil SS, Bin Shobri MA, Chinna K, Sahrir MS, Chidambaram K. Mode of delivery, order of birth, parental age gap and autism spectrum disorder among Malaysian children: a case-control study. Heliyon. 2020, 6:e05068. 10.1016\/j.heliyon.2020.e05068","journal-title":"Heliyon"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-18628-4","article-title":"Birth related parameters are important contributors in autism spectrum disorders","volume":"12","author":"Banerjee N","year":"2022","unstructured":"Banerjee N, Adak P. Birth related parameters are important contributors in autism spectrum disorders. Sci Rep. 2022, 12:14277. 10.1038\/s41598-022-18628-4","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4503871","article-title":"Significant changes in plasma alpha-synuclein and beta-synuclein levels in male children with autism spectrum disorder","volume":"2018","author":"Sriwimol W","year":"2018","unstructured":"Sriwimol W, Limprasert P. Significant changes in plasma alpha-synuclein and beta-synuclein levels in male children with autism spectrum disorder. Biomed Res Int. 2018, 2018:4503871. 10.1155\/2018\/4503871","journal-title":"Biomed Res Int"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/biom12010142","article-title":"\u03b2-Synuclein: an enigmatic protein with diverse functionality","volume":"12","author":"Hayashi J","year":"2022","unstructured":"Hayashi J, Carver JA. \u03b2-Synuclein: an enigmatic protein with diverse functionality. Biomolecules. 2022, 12:142. 10.3390\/biom12010142","journal-title":"Biomolecules"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148410","article-title":"Decreased levels of alpha synuclein in families with autism spectrum disorder and relationship between the disease severity","volume":"1814","author":"Karaca M","year":"2023","unstructured":"Karaca M, Tahtasakal R, Dana H, et al.. Decreased levels of alpha synuclein in families with autism spectrum disorder and relationship between the disease severity. Brain Res. 2023, 1814:148410. 10.1016\/j.brainres.2023.148410","journal-title":"Brain Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000112832","article-title":"Red blood cells are the major source of alpha-synuclein in blood","volume":"5","author":"Barbour R","year":"2008","unstructured":"Barbour R, Kling K, Anderson JP, et al.. Red blood cells are the major source of alpha-synuclein in blood. Neurodegener Dis. 2008, 5:55-9. 10.1159\/000112832","journal-title":"Neurodegener Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/280733-synucleins-as-biomarkers-of-severity-in-autism-spectrum-disorder","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T18:35:58Z","timestamp":1726252558000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/280733-synucleins-as-biomarkers-of-severity-in-autism-spectrum-disorder"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,13]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.69356","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,13]]}}}